États-Unis · Plateformes & données · Stocktwits

BMY Stock Falls 2% After Patient Death In Early Multiple Sclerosis CAR T Trial

Publié par Stocktwits · États-Unis il y a 8 h

Shares of Bristol Myers Squibb (BMY) dropped 2% on Friday after the company disclosed a patient death in its early-stage Breakfree-2 study of the experimental CAR T cell therapy,…

Lire l'article complet sur Stocktwits Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (stocktwits.com)

BMY Stock Falls 2% After Patient Death In Early Multiple Sclerosis CAR T Trial

À lire aussi

Tech stocks weigh on Nasdaq for second week; Roper leads gainers

Split $5,000 Across These 5 Dividend Stocks and Don't Look Until 2031

I want to pay off $4,500 in credit-card debt in 2 months. Is this possible?

After previous day’s slump, trading is quieter among AI shares

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders

BMY Stock Falls 2% After Patient Death In Early Multiple Sclerosis CAR T Trial

Partager

À lire aussi

Tech stocks weigh on Nasdaq for second week; Roper leads gainers

Split $5,000 Across These 5 Dividend Stocks and Don't Look Until 2031

I want to pay off $4,500 in credit-card debt in 2 months. Is this possible?

After previous day’s slump, trading is quieter among AI shares

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders